X
BNGO icon

Xponance’s Bionano Genomics BNGO Stock Holding History

Xponance’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-28
Closed -$18.9K – 1260
2023
Q1 		$18.9K Hold
28
– – ﹤0.01% 1216
2022
Q4 		$24.9K Buy
28
+1
+4% +$1.26K ﹤0.01% 1208
2022
Q3 		$30K Buy
27
+1
+4% +$1.32K ﹤0.01% 1171
2022
Q2 		$22K Buy
26
+3
+13% +$3.09K ﹤0.01% 1177
2022
Q1 		$36K Hold
23
– – ﹤0.01% 1149
2021
Q4 		$41K Buy
23
+1
+5% +$2.67K ﹤0.01% 1155
2021
Q3 		$73K Sell
22
-4
-15% -$14K ﹤0.01% 1147
2021
Q2 		$113K Buy
+26
New +$103K ﹤0.01% 1204

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Xponance's BNGO Position: Q2 2023 in Review

Xponance sold out of Bionano Genomics (BNGO) in Q2 2023, closing a stake of 28 shares — an estimated $18.9K sold.

Xponance first reported a position in BNGO in Q2 2021 and held it in 8 quarters. The position peaked at $113K in Q2 2021. 108 funds tracked by Wall St. Rank hold BNGO as of Q2 2023.

  • Xponance reported no remaining Bionano Genomics position as of Q2 2023 after selling out during the quarter.
  • Xponance sold 28 Bionano Genomics shares in Q2 2023, an estimated $18.9K.
  • Xponance first reported a position in Bionano Genomics in Q2 2021 and held it in 8 quarters.
  • Xponance's Bionano Genomics position peaked at $113K in Q2 2021.
  • 108 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2023.

Based on Xponance's 13F filing for Q2 2023, filed 14 Jul 2023.